A Val227Ala polymorphism in the peroxisome proliferator activated receptor alpha (PPARalpha) gene is associated with variations in serum lipid levels.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Medical Genetics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 11897821PMCID PMC1735067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Learning disorders and sex chromosome aberrations.

  2008cited by this paper
• Linear growth in patients with Turner syndrome: Influence of spontaneous puberty and parental height

  2005cited by this paper
• An uncommon phenotypical variant in the Shereshevsky-Turner syndrome

  2004cited by this paper
• Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers.

  2001cited by this paper
• Mutations in IHH, encoding Indian hedgehog, cause brachydactyly type A-1

  2001cited by this paper
• The broad autism phenotype: a complementary strategy for molecular genetic studies of autism.

  2001cited by this paper
• The Transition of Cadherin Expression in Osteoblast Differentiation from Mesenchymal Cells: Consistent Expression of Cadherin‐11 in Osteoblast Lineage

  2001cited by this paper
• ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses

  2001cited by this paper
• Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries.

  2001cited by this paper
• Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites

  2001cited by this paper
• A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases

  2001cited by this paper
• Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B

  2000cited by this paper
• Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome

  2000cited by this paper
• The Human 20-kDa 5′-(CGG) n -3′-binding Protein Is Targeted to the Nucleus and Affects the Activity of the FMR1Promoter*

  2000cited by this paper
• Clinical and radiological assessment of a family with mild brachydactyly type A1: the usefulness of metacarpophalangeal profiles

  2000cited by this paper
• Relative abundance of different cadherins defines differentiation of mesenchymal precursors into osteogenic, myogenic, or adipogenic pathways

  2000cited by this paper
• Roles of PPARs in health and disease

  2000cited by this paper
• The DNA damage response: putting checkpoints in perspective

  2000cited by this paper
• Rare variants in the promoter of the fragile X syndrome gene (FMR1).

  2000cited by this paper
• Peroxisome proliferator-activated receptors: insight into multiple cellular functions.

  2000cited by this paper
• Characterization of ATM mutations in 41 Nordic families with Ataxia Telangiectasia

  2000cited by this paper
• Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility.

  2000cited by this paper
• Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects

  2000cited by this paper
• The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants.

  2000cited by this paper
• Real-time quantitative polymerase chain reaction

  2000cited by this paper
• Possibilities of sterility therapy in a patient with a premature menopause due to an X-chromosomal anomaly - a case report.

  2000cited by this paper
• Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.

  2000cited by this paper
• Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA.

  2000cited by this paper
• Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate development

  2000cited by this paper
• Identification of a novel gene on chromosome 7q31 that is interrupted by a translocation breakpoint in an autistic individual.

  2000cited by this paper
• The Smith-Lemli-Opitz syndrome

  2000cited by this paper
• Intrachromosomal triplications: molecular cytogenetic and clinical studies

  2000cited by this paper
• Molecular scanning of the human PPARa gene: association of the L162v mutation with hyperapobetalipoproteinemia.

  2000cited by this paper
• Autism: recent molecular genetic advances.

  2000cited by this paper
• Inborn errors of cholesterol biosynthesis.

  2000cited by this paper
• Value of a clinical morphology examination in autism.

  2000cited by this paper
• A Role for N‐Cadherin in the Development of the Differentiated Osteoblastic Phenotype

  2000cited by this paper
• Female with autistic disorder and monosomy X (Turner syndrome): parent-of-origin effect of the X chromosome.

  2000cited by this paper
• Chromosome 22q11 deletions are not found in autistic patients identified using strict diagnostic criteria. IMGSAC. International Molecular Genetics Study of Autism Consortium.

  2000cited by this paper
• A Dominant Negative Cadherin Inhibits Osteoblast Differentiation

  2000cited by this paper
• A genomic screen of autism: evidence for a multilocus etiology.

  1999cited by this paper
• Chromosome breakage in the Prader-Willi and Angelman syndromes involves recombination between large, transcribed repeats at proximal and distal breakpoints.

  1999cited by this paper
• Ionizing radiation and genetic risks. VI. Chronic multifactorial diseases: a review of epidemiological and genetical aspects of coronary heart disease, essential hypertension and diabetes mellitus.

  1999cited by this paper
• Ataxia‐telangiectasia, cancer and the pathobiology of the ATM gene

  1999cited by this paper
• Etiology of infantile autism: a review of recent advances in genetic and neurobiological research.

  1999cited by this paper
• Fragile X syndrome with FMR1 and FMR2 deletion

  1999cited by this paper
• Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation.

  1999cited by this paper
• Intelligence Patterns Among Children with High-Functioning Autism, Phenylketonuria, and Childhood Head Injury

  1999cited by this paper
• An overview of genetic factors influencing plasma lipid levels and coronary artery disease risk.

  1999cited by this paper
• Psychosocial competence of unselected young adults with sex chromosome abnormalities.

  1999cited by this paper
• Eighth International Workshop on Ataxia-Telangiectasia (ATW8).

  1999cited by this paper
• Genetics and child psychiatry: II Empirical research findings.

  1999cited by this paper
• The ancestral gene for transcribed, low-copy repeats in the Prader-Willi/Angelman region encodes a large protein implicated in protein trafficking, which is deficient in mice with neuromuscular and spermiogenic abnormalities.

  1999cited by this paper
• An autosomal genomic screen for autism. Collaborative linkage study of autism.

  1999cited by this paper
• No Evidence of a Major Locus for Benign Familial Infantile Convulsions on Chromosome 19q12‐q13.1

  1999cited by this paper
• Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay.

  1999cited by this paper
• Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3).

  1999cited by this paper
• Microcephaly and Macrocephaly in Autism

  1999cited by this paper
• Prenatal binge-like alcohol exposure in the rat results in region-specific deficits in brain growth.

  1999cited by this paper
• Rapid and efficient ATM mutation detection by fluorescent chemical cleavage of mismatch: identification of four novel mutations

  1999cited by this paper
• Chromosomal Abnormalities in a Series of Children with Autistic Disorder

  1999cited by this paper
• Xp deletions associated with autism in three females

  1999cited by this paper
• The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence.

  1999cited by this paper
• Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging.

  1999cited by this paper
• Subtle chromosomal rearrangements in children with unexplained mental retardation.

  1999cited by this paper
• Molecular genetics of the Finnish disease heritage.

  1999cited by this paper
• FMRP expression as a potential prognostic indicator in fragile X syndrome.

  1999cited by this paper
• Nonrandom X inactivation and selection of fragile X full mutation in fetal fibroblasts.

  1999cited by this paper
• Genetics of limb anomalies in humans.

  1999cited by this paper
• Imprinting-mutation mechanisms in Prader-Willi syndrome.

  1999cited by this paper
• Deletion of 8.5 Mb, including the FMR1 gene, in a male with the fragile X syndrome phenotype and overgrowth.

  1999cited by this paper
• Paternally derived de novo interstitial duplication of proximal 15q in a patient with developmental delay.

  1999cited by this paper
• An MRI study of the basal ganglia in autism.

  1999cited by this paper
• Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations.

  1999cited by this paper
• Mechanism of action of fibrates on lipid and lipoprotein metabolism.

  1998cited by this paper
• Delineation of supernumerary marker chromosomes in 38 patients.

  1998cited by this paper
• Purified Recombinant Fmrp Exhibits Selective RNA Binding as an Intrinsic Property of the Fragile X Mental Retardation Protein*

  1998cited by this paper
• A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family

  1998cited by this paper
• Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group.

  1998cited by this paper
• Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients.

  1998cited by this paper
• How Commonly Are Known Medical Conditions Associated with Autism?

  1998cited by this paper
• Identical mutation in 55% of the ATM alleles in 11 Norwegian AT families: evidence for a founder effect

  1998cited by this paper
• Autism and maternally derived aberrations of chromosome 15q.

  1998cited by this paper
• Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations.

  1998cited by this paper
• A review of the neuroanatomical findings in children with fetal alcohol syndrome or prenatal exposure to alcohol.

  1998cited by this paper
• The fragile X syndrome.

  1998cited by this paper
• A clinical, cytogenetic and molecular study of ten probands with supernumerary inv dup (15) marker chromosomes

  1998cited by this paper
• A large polymorphic repeat in the pericentromeric region of human chromosome 15q contains three partial gene duplications.

  1998cited by this paper
• Interstitial duplications of chromosome region 15q11q13: clinical and molecular characterization.

  1998cited by this paper
• Peroxisome Proliferator-activated Receptor α-Isoform Deficiency Leads to Progressive Dyslipidemia with Sexually Dimorphic Obesity and Steatosis*

  1998cited by this paper
• Autistic Behavior in Young Boys with Fragile X Syndrome

  1998cited by this paper
• Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia.

  1998cited by this paper
• Mutations of the ATM gene detected in Japanese ataxia-telangiectasia patients: possible preponderance of the two founder mutations 4612del165 and 7883del5

  1998cited by this paper
• Evidence of founder mutations in Finnish BRCA1 and BRCA2 families.

  1998cited by this paper
• Brachydactyly type A1 with abnormal menisci and scoliosis in three generations

  1998cited by this paper
• Cadherin-6 Mediates the Heterotypic Interactions between the Hemopoietic Osteoclast Cell Lineage and Stromal Cells in a Murine Model of Osteoclast Differentiation

  1998cited by this paper
• ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer.

  1998cited by this paper
• ATM mutations in patients with ataxia telangiectasia screened by a hierarchical strategy

  1998cited by this paper
• Chromosomal Disorders and Autism

  1998cited by this paper
• A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice.

  1998cited by this paper

• PPARɑ variant V227A reduces plasma triglycerides through enhanced lipoprotein lipolysis

  2025cites this paper
• PPARA variant rs1800234 had a dose dependent pharmacogenetics impact on the therapeutic response to chiglitazar.

  2024cites this paper
• LINC317.5 as a novel biomarker for hypertriglyceridemia in abnormal glucose metabolism

  2024cites this paper
• Population‐based meta‐analysis and gene‐set enrichment identifies FXR/RXR pathway as common to fatty liver disease and serum lipids

  2022cites this paper
• The Influence of the Differentiation of Genes Encoding Peroxisome Proliferator-Activated Receptors and Their Coactivators on Nutrient and Energy Metabolism

  2022cites this paper
• Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD).

  2021cites this paper
• Impact of PPAR-Alpha Polymorphisms—The Case of Metabolic Disorders and Atherosclerosis

  2019cites this paper
• Molecular Actions of PPARα in Lipid Metabolism and Inflammation.

  2018cites this paper
• The Contribution of Genetic Variants of the Peroxisome Proliferator-Activated Receptor-Alpha Gene to High-Altitude Hypoxia Adaptation in Sherpa Highlanders

  2018cites this paper
• The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions

  2017cites this paper
• Genomic studies in non-alcoholic fatty liver disease

  2017influential citation
• Significance of genetic polymorphisms in patients with nonalcoholic fatty liver disease

  2017cites this paper
• Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease.

  2016cites this paper
• Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.

  2016cites this paper
• Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

  2015cites this paper
• The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2

  2015cites this paper
• Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study

  2014cites this paper
• Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment

  2013cites this paper
• PPAR-α as a key nutritional and environmental sensor for metabolic adaptation.

  2013cites this paper
• NAFLD in Asia—as common and important as in the West

  2013cites this paper
• Genomic aspects of NAFLD pathogenesis.

  2013cites this paper
• Mechanistic considerations for human relevance of cancer hazard of di(2-ethylhexyl) phthalate.

  2012cites this paper
• Peroxisome Proliferator-Activated Receptor Alpha Target Genes

  2010cites this paper
• Adipocytokine polymorphisms and nonalcoholic fatty liver disease

  2009cites this paper
• Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiolog

  2009cites this paper
• Peroxisome proliferator–activated receptor α genetic variation interacts with n–6 and long-chain n–3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study1,2,3

  2009cites this paper
• PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease

  2008cites this paper
• Single gene contributions: genetic variants of peroxisome proliferator-activated receptor (isoforms α, β/δ and γ) and mechanisms of dyslipidemias

  2008cites this paper
• Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study.

  2008cites this paper
• A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non‐alcoholic fatty liver disease and decreased waist circumference and waist‐to‐hip ratio

  2008cites this paper
• A natural polymorphism in peroxisome proliferator-activated receptor-alpha hinge region attenuates transcription due to defective release of nuclear receptor corepressor from chromatin.

  2008cites this paper
• Differential Effects of Aging, Drinking and Exercise on Serum Cholesterol Levels Dependent on the PPARA‐V227A Polymorphism

  2007cites this paper
• Association of V227A PPAR&agr; polymorphism with altered serum biochemistry and alcohol drinking in Japanese men

  2006cites this paper
• Gly395Arg polymorphism of PPARalpha gene was not detected in Japanese population of 729 individuals.

  2006cites this paper
• The V227A polymorphism at the PPARA locus is associated with serum lipid concentrations and modulates the association between dietary polyunsaturated fatty acid intake and serum high density lipoprotein concentrations in Chinese women.

  2006cites this paper
• ANALYSIS OF THE TERTIARY STRUCTURE OF THE PPAR AND RXR TRANSCRIPTIONAL FACTORS AND THEIR MUTANT VARIANTS

  2006cites this paper
• Peroxisome proliferator-activated receptor-α and liver cancer: where do we stand?

  2005cites this paper
• Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?

  2005cites this paper
• Evidence of differing genotypic effects of PPARalpha in women and men.

  2004cites this paper
• Detection and localization of quantitative trait loci affecting fatness in broilers.

  2004cites this paper
• Peroxisome proliferator-activated receptor alpha target genes.

  2004cites this paper
• Evidence of differing genotypic effects of PPARα in women and men

  2004cites this paper
• Evidence for an association between the Leu162Val polymorphism of the PPARalpha gene and decreased fasting serum triglyceride levels in glucose tolerant subjects.

  2003cites this paper
• Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression?

  2003cites this paper
• PPARalpha agonist-induced rodent tumors: modes of action and human relevance.

  2003cites this paper
• PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance

  2003cites this paper